Indian Journal of Medical Microbiology IAMM  | About us |  Subscription |  e-Alerts  | Feedback |  Login   
  Print this page Email this page   Small font sizeDefault font sizeIncrease font size
 Home | Ahead of Print | Current Issue | Archives | Search | Instructions  
Users Online: 103 Official Publication of Indian Association of Medical Microbiologists 
  Search
 
 ~ Next article
 ~ Previous article 
 ~ Table of Contents
  
 ~  Similar in PUBMED
 ~  Search Pubmed for
 ~  Search in Google Scholar for
 ~  Article in PDF (29 KB)
 ~  Citation Manager
 ~  Access Statistics
 ~  Reader Comments
 ~  Email Alert *
 ~  Add to My List *
* Registration required (free)  

 
 ~  References

 Article Access Statistics
    Viewed3435    
    Printed65    
    Emailed2    
    PDF Downloaded321    
    Comments [Add]    

Recommend this journal

 


 
CORRESPONDENCE
Year : 2006  |  Volume : 24  |  Issue : 4  |  Page : 304
 

β-lactam antibiotic susceptibility testing of MRSA?


Department of Microbiology, Indira Gandhi Government Medical College, Nagpur - 440 018, Maharashatra, India

Date of Submission12-Apr-2006
Date of Acceptance07-Jul-2006

Correspondence Address:
S V Jalgaonkar
Department of Microbiology, Indira Gandhi Government Medical College, Nagpur - 440 018, Maharashatra
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0255-0857.29400

Rights and Permissions



How to cite this article:
Agrawal G, Jalgaonkar S V. β-lactam antibiotic susceptibility testing of MRSA?. Indian J Med Microbiol 2006;24:304

How to cite this URL:
Agrawal G, Jalgaonkar S V. β-lactam antibiotic susceptibility testing of MRSA?. Indian J Med Microbiol [serial online] 2006 [cited 2019 Aug 22];24:304. Available from: http://www.ijmm.org/text.asp?2006/24/4/304/29400


Dear Editor,

We want to congratulate Dr. K. Rajaduraipandi and colleagues for sharing the data on methicillin resistant Staphylococcus aureus (MRSA) from southern districts of Tamilnadu.[1] Although, the work is carefully and critically done, some clarifications are needed.

Having carefully gone through the article, it was very difficult to understand as to why the sensitivity of MRSA strains to penicillins and cephems has been reported by the authors. As per NCCLS,[2] oxacillin-resistant staphylococci are resistant to all currently available β -lactam antibiotics. Further, routine testing of other penicillins, β -lactamase inhibitor combinations, cephems and carbapenems is not advised. NCCLS[2] gives warning that, for oxacillin-resistant Staphylococcus aureus , all penicillins, cephems and other β -lactams may appear active in vitro but are not effective clinically and isolates should not be tested and reported as susceptible.

Authors have tested MRSA isolates for susceptibility to penicillins viz. penicillin G, ampicillin, cloxacillin and cephems viz. cephalexin, cephotaxime and reported some of the strains as susceptible to them. As many as 0.04% and 69.2% of MRSA isolates from clinical samples were shown to be susceptible to penicillin G and cloxacillin respectively. NCCLS [2] recommends that, of the antistaphylococcal β -lactamase-stable penicillins, oxacillin can be tested and results can be applied to other penicillinase-stable penicillins, cloxacillin and dicloxacillin. Cloxacillin disks should not be used, because they may not detect oxacillin-resistant Staphylococcus aureus .

Through this letter, we would like to emphasize strict adherance to NCCLS guidelines that serve as standard for uniformity and are based on sound technical background. This will also avoid misleading the clinicians for the choice of drug for effective patient management.

 
 ~ References Top

1.Rajaduraipandi K, Mani KR, Panneerselvam K, Mani M, Bhaskar M, Manikandan P. Prevalence and antimicrobial susceptibility pattern of methicillin resistant Staphylococcus aureus : A multicenter study. Indian J Med Microbiol 2006; 24 :34-8.  Back to cited text no. 1  [PUBMED]  [FULLTEXT]
2.National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing: 12th informational supplement. NCCLS: Pennsylvania, USA; 2002. p. M100-S12.  Back to cited text no. 2    




 

Top
Print this article  Email this article
Previous article Next article

    

2004 - Indian Journal of Medical Microbiology
Published by Wolters Kluwer - Medknow

Online since April 2001, new site since 1st August '04